4//SEC Filing
Barlow Carrolee 4
Accession 0001104659-20-024853
CIK 0001356576other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:24 PM ET
Size
7.0 KB
Accession
0001104659-20-024853
Insider Transaction Report
Form 4
Barlow Carrolee
Director
Transactions
- Award
Common Stock
2020-02-21$23.99/sh+5,211$125,012→ 5,211 total - Award
Director Stock Option (Right to Buy)
2020-02-21+9,305→ 9,305 totalExercise: $23.99From: 2021-02-21Exp: 2030-02-21→ Common Stock (9,305 underlying)
Footnotes (1)
- [F1]Represents restricted stock unit component of the annual equity compensation to directors. These shares will be settled in common stock upon vesting, such vesting to occur on February 21, 2021. Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001745316
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:24 PM ET
- Size
- 7.0 KB